Halozyme Therapeutics Inc (NASDAQ:HALO)

BATS BZX Real-Time Price
As of 2:38pm ET
 +1.16 / +6.28%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 11 analysts offering 12-month price forecasts for Halozyme Therapeutics Inc have a median target of 20.00, with a high estimate of 33.00 and a low estimate of 9.00. The median estimate represents a +1.83% increase from the last price of 19.64.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Halozyme Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 21

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 3,516.20%
Growthannually 139.74%


Growthquarterly 163.04%
Growthannually 100.95%
Key to the earnings and sales forecast charts.